Pascal Pujol

Exemestane for Breast-Cancer Prevention in Postmenopausal Women

Paul E. Goss, James N. Ingle, José E. Alés‐Martínez et al. · New England Journal of Medicine · 2011 · 952 citations · Full text

Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer.

Pascal Pujol, Jean Pierre Daurès, N Nsakala et al. · The Journal of Clinical Endocrinology & Metabolism · 1996 · 271 citations · Full text

Surgical Oncology, Pathology, Thyrotropin Suppression +17

Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis.

Pascal Pujol, Jean‐Marc Rey, Philippe Nirdé et al. · PubMed · 1998 · 209 citations

Estrogen Receptor-alpha, Estrogen Receptor, Gynecology +18

Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor

Richard H. Scott, Jenny Douglas, Linda Baskcomb et al. · Nature Genetics · 2008 · 197 citations

Nonsyndromic Wilms Tumor, Developmental Anomaly, Developmental Biology +11

Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families

Sophie Gad, Virginie Caux‐Moncoutier, Sabine Pagès-Berhouet et al. · Oncogene · 2002 · 188 citations

Breast Oncology, Somatic Variant, Tumor Heterogeneity +13